<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">Our findings demonstrate that we must make improvements in order to offer patients, and their treating clinicians, evidence-based care during pandemics, including the COVID-19 pandemic. Several drugs are being investigated as potential treatment for COVID-19, but we note that some early published studies were poorly controlled [
 <xref ref-type="bibr" rid="CR16">16</xref>, 
 <xref ref-type="bibr" rid="CR17">17</xref>]. It is imperative that we learn from the A(H1N1)pdm09 pandemic and ensure that trials of therapeutics are done under conditions which allow for the collection of high-quality, interpretable data to inform future clinical care.
</p>
